Skip to main content

Posts

Showing posts from 2018

AICR Publishes Recommendations for Cancer Prevention

Financial professional Gary Fournier serves as a managing director for JP Morgan in Los Angeles, where he manages the financial portfolios of high-net-worth individuals. Additionally, Gary Fournier supports a number of organizations that pursue essential research discoveries related to cancer, including the American Institute of Cancer Research (AICR).  AICR was founded on the principle that some cancers can be prevented with a concentrated focus on lifestyle choices. To this end, the organizations has published a list of recommendations for cancer prevention. These recommendations are evidence-based conclusions derived from rigorous research and reports. Here are a few of them: 1. Maintain a healthy weigh t. Research shows that maintaining a weight that is on the lower end of the body mass index recommendations can dramatically decrease the risk of cancer and other chronic diseases. 2. Engage in 30 minutes of physical activity per day. Exercise has been shown to strengthen the imm

The Debi and Gary Fournier Cervical Cancer Research Fund

Gary Fournier manages in excess of $1 billion in client assets in his role as managing director with JP Morgan in Los Angeles. A supporter of a number of charitable causes, Mr. Fournier has joined with his wife in forming the Debi and Gary Fournier Cervical Cancer Research Fund. In partnership with the Jonsson Center Cancer Foundation at UCLA, the Debi and Gary Fournier Cervical Cancer Research Fund works to benefit the more than 500,000 women each year who receive a cervical cancer diagnosis. The fund, which was established following Mrs. Fournier’s 2011 diagnosis with cervical cancer, supports research at the UCLA Jonsson Comprehensive Cancer Center/Translational Oncology Research Lab.  Currently, the Fourniers’ fund is helping the UCLA Jonsson Comprehensive Cancer Center/Translational Oncology Research Lab to study cancer cell lines in an effort to foster a deeper understanding of the disease. In the future, and with the fund’s financial assistance, UCLA researchers plan to use t